NCT05586438View on ClinicalTrials.gov

Pharmacokinetics of Colistin in Critically-ill Patients With AKI Who Receive SLED

PHASE4CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

October 18, 2021

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions
Bacterial Infections
Interventions
DRUG

Colistin Sulfomethate

The patients receive colistin 150 mg intravenous once daily on non-dialysis day and receive colistin 150 mg intravenous every 12 hours on dialysis day

Trial Locations (1)

10700

Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok

All Listed Sponsors
collaborator

Monash University

OTHER

lead

Mahidol University

OTHER

NCT05586438 - Pharmacokinetics of Colistin in Critically-ill Patients With AKI Who Receive SLED | Biotech Hunter | Biotech Hunter